ArticleDiabetes, obesity & metabolism2025
Prevalence and concordance of cardiometabolic risk markers and health behaviour among couples after a gestational diabetes mellitus-affected pregnancy.
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and concordance of cardiometabolic risk markers and health behaviour among couples after a gestational diabetes mellitus-affected pregnancy.Diabetes, obesity & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
aimsThis study investigated the prevalence and concordance of cardiometabolic risk markers among couples after a gestational diabetes mellitus (GDM)-affected pregnancy. It also examined whether selected demographic, socioeconomic and health behavioural factors could explain within-couple associations. MATERIALS AND
methodsA cross-sectional study design was used. We included health examinations and questionnaire data from couples assessed 12 weeks after a pregnancy affected by GDM. We determined the prevalence and concordance of cardiometabolic risk markers (overweight or obesity, high waist circumference, metabolic syndrome, impaired fasting glucose [≥6.1 mmol/L], and stage 1 hypertension or more [≥130 mmHg/≥80 mmHg], along with health behaviour [dietary quality and physical activity]).
resultsA total of 196 couples were included. Overweight or obesity was present in 63.3% of women and 71.9% of partners, with concordance observed in 50.5% of couples. By comparison, 78.6% of women and 55.1% of partners had high waist circumferences, which was concordant in 48.5% of couples. Metabolic syndrome was identified in 9.2% of women and 24.0% of partners, suggesting a higher occurrence among partners with concordance in 5.1% of couples. Impaired fasting glucose was observed in 7.7% of women and 9.2% of partners, with concordance in 1.5% of couples. Stage 1 hypertension or more was observed in 31.1% of the women, 55.6% of the partners and concordant in 8.2% of couples. Cardiometabolic risk markers were associated within couples.
conclusionsDetecting GDM in women may serve as an opportunity to identify partners at risk, underscoring the potential of couple-based or family-focused interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.